Anatomical and functional results after surgical treatment of uterine leiomyoma combined with genital prolapse

Authors

DOI:

https://doi.org/10.15574/HW.2023.166.25

Keywords:

uterine leiomyoma, genital prolapse, pelvic surgery

Abstract

More than 41% of women aged 50-79 suffer from pelvic organ prolapse. Genital prolapse is combined with uterine leiomyoma in approximately 20% of cases, which necessitates a differentiated approach to the treatment.

Purpose - to compare the anatomical and functional results of surgical treatment of women with uterine leiomyoma combined with genital prolapse, who underwent hysterectomy with and without prolapse correction.

Materials and methods. 80 patients with genital prolapse combined with uterine leiomyoma were examined and divided into three groups. In the Control (I) Group (n=40), hysterectomy was performed without correction of genital prolapse, in the other two groups - hysterectomy and correction of genital prolapse using a mesh implant by the method of pectopexy (the Group II, n=40) or lateral fixation (the Group III, n=40). Anatomical and functional outcomes were assessed 6 and 12 months postoperatively using the POP-Q and the questionnair PFDI-20 and PISQ-12. Statistical analysis was performed with SPSS Version 21.0. 

Results. In women of the Groups II and III, POP-Q parameters significantly improved 6-12 months after surgery compared to the initial level, while in patients of the Group I, 1 year after surgery, negative dynamics of changes in points Aa, Ba and indicators of pb and Tvl were established. Anatomical success, which is POP-Q stage 0-1 one year after surgery and does not require further surgical treatment, was 82.5% in the Group II and 85% in the Group III. The frequency of improvement of pelvic functions according to PEDI-20 and the state of sexual function according to PISQ-12 6 months after the operation was significantly higher among women of the Groups II and III comparing to the Group I.

Conclusions. The obtained data testify to the anatomical effectiveness of simultaneous hysterectomy and correction of genital prolapse using mesh implants.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.

No conflict of interests was declared by the authors.

References

Abdel-Fattah M, Ramsay I. (2008). Retrospective multicentre study of the new minimally invasive mesh repair devices for pelvic organ prolapse. BJOG. 115 (1): 22-30. https://doi.org/10.1111/j.1471-0528.2007.01558.x; PMid:18053100

Barber MD, Walters MD, Bump RC. (2005). Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 193 (1): 103-113. https://doi.org/10.1016/j.ajog.2004.12.025; PMid:16021067

Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. (2007). Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 109 (4): 848-854. https://doi.org/10.1097/01.AOG.0000255977.91296.5d; PMid:17400845

Brown RA. Ellis CN. (2014). The role of synthetic and biologic materials in the treatment of pelvic organ prolapse. Clin Colon Rectal Surg. 27 (4): 182-190. https://doi.org/10.1055/s-0034-1394157; PMid:25435827 PMCid:PMC4226752

Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P et al. (1996). The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 175 (1): 10-17. https://doi.org/10.1016/S0002-9378(96)70243-0; PMid:8694033

Cramer SF, Patel A. (1990). The frequency of uterine leiomyomas. Am J Clin Pathol. 94 (4): 435-438. https://doi.org/10.1093/ajcp/94.4.435; PMid:2220671

Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd SL, Maroulis C, Subramanian D. (2010). The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol. 152 (1): 96-102. https://doi.org/10.1016/j.ejogrb.2010.05.012; PMid:20598796

Fatton B, Amblard J, Debodinance P, Cosson M, Jacquetin B. (2007). Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (ProliftTM technique) - a case series multicentric study. Int Urogynecol J Pelvic Floor Dysfunct. 18 (7): 743-752. https://doi.org/10.1007/s00192-006-0234-3; PMid:17131170

Golyanovskiy OV, Kachur OYu, Budchenko MА, Supruniuk KV, Frolov SV. (2021). Uterine leiomyoma: modern aspects of clinic, diagnosis and treatment. Reproductive health of woman. 5 (5): 7-18. https://doi.org/10.30841/2708-8731.5.2021.240017

Jacquetin B, Jacquetin B, Fatton B, Rosenthal C, Clavé H, Debodinance P, Hinoul P, Gauld J, Garbin O, Berrocal J, Villet R, Salet Lizée D, Cosson M. (2010). Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 3-year prospective follow-up study. Int Urogynecol J. 21 (12): 1455-1462. https://doi.org/10.1007/s00192-010-1223-0; PMid:20683579

Kuzemensky ML, Gladenko SE. (2015). Tactics of operative treatment complex pathologies of uterus without and with genital prolapse. Health of woman. 4 (100): 78-79.

Long CY, Hsu CS, Jang MY, Liu CM, Chiang PH, Tsai EM. (2010). Comparison of clinical outcome and urodynamic findings using "Perigee and/or Apogee" versus "Prolift anterior and/or posterior" system devices for the treatment of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 22 (2): 233-239. https://doi.org/10.1007/s00192-010-1262-6; PMid:20830581

Lytvynenko OV, Gromova AM, Sakevich RP. (2013). Evaluation of the quality of life in women with uterine leiomyoma after uterine arterial embolization using SF-36 and UFS-QOL questionnaires. Tavrichesky Medico-Biological Bulletin. 2 (2): 62-65.

Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. (1997). Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 89 (4): 501-566. https://doi.org/10.1016/S0029-7844(97)00058-6; PMid:9083302

Reynolds WS, Gold KP, Ni S, Kaufman MR, Dmochowski RR, Penson DF. (2013). Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries. Neurourol Urodyn. 32 (4): 330-335. https://doi.org/10.1002/nau.22318; PMid:23001605 PMCid:PMC3962985

Rogers RG, Kammerer-Doak D, Darrow A, Murray K, Olsen A, Barber M et al. (2004). Sexual function after surgery for stress urinary incontinence and/or pelvic organ prolapse: A multicenter prospective study. Am J Obstet Gynecol. 191 (1): 206-210. https://doi.org/10.1016/j.ajog.2004.03.087; PMid:15295367

Smith FJ, Holman CD, Moorin RE, Tsokos N. (2010). Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 116 (5): 1096-1100. https://doi.org/10.1097/AOG.0b013e3181f73729; PMid:20966694

Tatarchuk TF, Kosey NV. (2012). Sovremennye principy lecheniya lejomiomy matki. Zdorov'ya Ukraїni: med. gazeta. 4 (Gіnekologіya. Akusherstvo. Reproduktologіya): 10-13.

Vaiyapuri GR, Han HC, Lee LC, Tseng LA, Wong HF. (2011). Use of the Gynecare Prolift(R) system in surgery for pelvic organ prolapse: 1-year outcome. Int Urogynecol J Pelvic Floor Dysfunct. 22 (7): 869-877. https://doi.org/10.1007/s00192-011-1400-9; PMid:21479713

Zhelezov DM. (2021). Osoblivostі MRT-vіzualіzacії mіom matki na peredoperacіjnomu etapі. Vіsnik medichnih і bіologіchnih doslіdzhen'. 1 (7): 62-65.

Published

2023-06-30